Profil
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Ehemalige bekannte Positionen von Xavier Avat
| Unternehmen | Position | Ende |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01.04.2023 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Xavier Avat
| École des Hautes Études Commerciales du Nord | Masters Business Admin |
| Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
